Cravens & Co Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$936K Buy
9,117
+555
+6% +$62.7K 0.61% 37
2025
Q4
$1.06M Sell
8,562
-578
-6% -$73.6K 0.7% 33
2025
Q3
$1.22M Buy
9,140
+515
+6% +$67.6K 0.84% 27
2025
Q2
$1.17M Sell
8,625
-21
-0.2% -$2.77K 0.88% 28
2025
Q1
$1.15M Sell
8,646
-293
-3% -$37.3K 0.89% 25
2024
Q4
$1.01M Buy
8,939
+145
+2% +$16.8K 0.77% 28
2024
Q3
$1M Sell
8,794
-886
-9% -$97.2K 0.77% 27
2024
Q2
$1.01M Buy
9,680
+2,427
+33% +$257K 0.75% 31
2024
Q1
$824K Buy
7,253
+344
+5% +$39.4K 0.68% 31
2023
Q4
$760K Sell
6,909
-296
-4% -$29.6K 0.66% 37
2023
Q3
$698K Buy
7,205
+118
+2% +$12.4K 0.66% 37
2023
Q2
$773K Sell
7,087
-25
-0.4% -$2.67K 0.71% 34
2023
Q1
$720K Buy
7,112
+170
+2% +$17.9K 0.67% 33
2022
Q4
$762K Buy
+6,942
New +$719K 0.71% 28

Other funds holding ABT

Cravens & Co Advisors's ABT Position: Q1 2026 in Review

Cravens & Co Advisors increased its Abbott (ABT) stake by 6.5% in Q1 2026, buying an estimated $62.7K and bringing the position to 9,117 shares worth $936K. The position accounts for 0.61% of the portfolio, ranked #37.

Cravens & Co Advisors first reported a position in ABT in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.22M in Q3 2025. 3,084 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Cravens & Co Advisors held 9,117 shares of Abbott worth $936K as of Q1 2026.
  • Cravens & Co Advisors bought 555 Abbott shares in Q1 2026, an estimated $62.7K.
  • Abbott made up 0.61% of Cravens & Co Advisors's portfolio in Q1 2026, its #37 holding.
  • Cravens & Co Advisors first reported a position in Abbott in Q4 2022 and has held it in 14 quarters since.
  • Cravens & Co Advisors's Abbott position peaked at $1.22M in Q3 2025.
  • 3,084 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Cravens & Co Advisors's 13F filing for Q1 2026, filed 14 May 2026.